25 years of normalizing tumor vasculature: what have we learned? Our new @CellCellPress review looks back at the science, the surprises, and the path forward for anti-angiogenic therapy in cancer. https://t.co/TDR9j90EBk #TumorMicroenvironment#Angiogenesis#CancerResearch
Publication Alert 🚨 - Organ-specific breast cancer metastasis reflects complex nutrient–tumor interactions, not single metabolites. Purine synthesis is a conserved vulnerability. https://t.co/Ol4FV5UCyF @harvardmed@MIT@kochinstitute
How a once-fringe scientific idea transformed our understanding of tumor biology and led to lifesaving cancer treatments.
A great conversation with Dr. Rakesh K. Jain @MGHSteeleLabs on Science Friday.
🎧 Listen here: https://t.co/bnNGQfqajq
via @scifri
Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer - Martin - Advanced Science - Wiley Online Library https://t.co/heIyKPRF6q
New from our lab in @PNASNews: we developed a physiologically based model to optimize CAR-T therapy in solid tumors. Vascular normalization can cut CAR-T doses 5x & boost efficacy in tumors like #GBM and #PDAC. https://t.co/aasFEHyc3g #SystemsBiology@lancemunn@MGBResearchNews
Join us for the 40th Annual Critical Issues in Tumor Microenvironment, Nov 10th-14th, 2025; Harvard/MIT affiliates: email [email protected] for discount code. Trainees: submit abstracts for poster presentations! https://t.co/fhIyBGflDp
Excited to share our new review on immune checkpoint blockade in the tumor microenvironment, now out in @NatureCancer. Congrats to the whole team.
https://t.co/vzQ1wcDy9l